2024
|
Invention
|
Infectious plasmodium sporozoites grown in vitro.
The application is directed to in vitro-reared... |
2023
|
Invention
|
Infectious plasmodium sporozoites grown in vitro. P. knowlesi, wherein sporogony from gametocyte ... |
|
Invention
|
Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use.
Antibod... |
2022
|
Invention
|
Live attenuated oral vaccine against shigellosis and typhoid fever.
Disclosed is the attenuated ... |
2021
|
Invention
|
Live attenuated oral vaccine against covid-19 and typhoid fever.
Disclosed herein are transgenic... |
|
Invention
|
Plasmodium sporozoites grown in vitro. P. knowlesi, wherein sporogony from gametocyte stage to sp... |
|
Invention
|
Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use. P. falci... |
2020
|
Invention
|
Apparatus and method of use for an automated mosquito salivary gland extraction device. Plasmodiu... |
|
Invention
|
Mosquito egg cryopreservation.
Herein is described a method devised to cryopreserve mosquito egg... |
|
Invention
|
Mosquito egg cryopreservation. Herein is described a method devised to cryopreserve mosquito eggs... |
|
Invention
|
Live attenuated oral vaccine against etec and typhoid fever. Shigella sonnei form 1 O-antigen, as... |
2019
|
Invention
|
Container and cap assembly for cryogenic storage. Disclosed are container and cap assemblies for ... |
2018
|
Invention
|
Neutralizing antibodies to plasmodium falciparum circumsporozoite protein and their use. Antibodi... |
2017
|
Invention
|
Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccin... |
|
Invention
|
Mosquito salivary gland extraction device and methods of use. Plasmodium primarily resides. Sporo... |
|
Invention
|
Purified plasmodium and vaccine compositions. Plasmodium sporozoites are also provided. |
|
Invention
|
Genetic attenuation of plasmodium by b9 gene disruption. Plasmodium sporozoites as well as method... |
2016
|
Invention
|
Live attenuated oral vaccine against shigellosis and typhoid fever. Shigella sonnei form 1 O-anti... |
|
Invention
|
Plasmodium sporozoites and glycolipid adjuvants. Plasmodium and analogues of α-galactosylceramide... |
2015
|
Invention
|
Infectious plasmodium sporozoites grown in vitro. The application is directed to in vitro-reared ... |
2014
|
Invention
|
Plasmodium by b9 gene disruption. Plasmodium sporozoites as well as methods of using the same are... |
|
Invention
|
Genetic attenuation of plasmodium by b9 gene disruption. Disclosed herein are mutant Plasmodium-s... |
2012
|
Invention
|
Plasmodium and vaccine composition. Plasmodium sporozoites are also provided. |
2011
|
Invention
|
Methods for the prevention of malaria.
This application relates to preventing malaria by adminis... |
2010
|
Invention
|
Malaria vaccines.
Transcript profiles for irradiated and non-irradiated P. falciparum sporozoite... |
|
Invention
|
Purified plasmodium and vaccine compositions. Plasmodium sporozoites are likewise provided. Metho... |
|
Invention
|
Purified plasmodium and vaccine compositions. Disclosed are substantially purified Plasmodium spo... |
2007
|
Invention
|
Apparatuses and methods for the production of haematophagous organisms and parasites suitable for... |
2006
|
Invention
|
Plasmodium vivax. P. vivax. Each molecule comprises sequences corresponding to several repeats of... |
2005
|
Invention
|
Methods for the prevention of malaria.
The invention comprises novel compositions and methods fo... |
|
Invention
|
Methods for the prevention of malaria.
The invention comprises a novel method for protecting sub... |
2003
|
Invention
|
Method for the prevention of malaria. The invention comprises a novel method for protecting subje... |
|
Invention
|
Production of haematophagous organisms and parasites suitable for vaccine production. Disclosed a... |